Furthermore, it was demonstrated that TET2, IDH1, and IDH2 gene mutations were driver mutations (that probably have a role in the pathogenesis of the disorder) and are acquired with the evolution of MDS to AML. Here, IDH2 is linked to acute myeloid leukemia.